Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. The Group’s main products are contrast agents sold in over 100 countries, both directly and indirectly through branches, joint ventures and license and distribution agreements.
We are looking for a Global Director of Marketing Operations to take a leading role in increasing marketing's business contribution – optimizing and operationalizing marketing strategy, processes, planning, data management, and measurement, and enabling marketing to become a more efficient and effective function.
Joining a growing and dynamic global marketing organization, this individual will work alongside the Chief Marketing Officer (CMO) to elevate the perception and value marketing delivers to the business, with a strong focus on return on marketing investment.
This role serves as the operational engine behind product launches and campaign effectiveness, translating global product vision into structured, executable launch plans and campaigns, and orchestrating alignment between global and regional plans.
A critical part of the role is leading Marketing Excellence training and building a common marketing DNA across all Business Units and Regions, providing guidance, support, and professional development opportunities.
A defining priority of this role is to design, launch, and lead a new global Customer Experience Center of Excellence (CX COE), establishing it as the organization's dedicated hub for customer experience strategy, methodology, tools, and capability-building across all Business Units and Regions.
The position also plays a pivotal role in providing strategic direction and hands-on leadership for global marketing, with responsibilities spanning coordination of the Marketing Council and program priorities, optimization of work-planning and management tools such as the Annual Marketing Plans, governance of data privacy and compliance, and fostering a culture of innovation and collaboration within the marketing department – ensuring marketing efforts are cohesive, measurable, and aligned with business objectives.
Bachelor's degree required; MBA preferred, with a focus on business, marketing, communications, or healthcare management.
Permanent
If you meet the requirements of this opportunity and would like to join an international group working to improve patients' lives, apply now!
At Bracco, we believe in the values of diversity and inclusion. We respect and celebrate the diversity of our people and their experiences, ensuring a fair opportunity for all.

Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,700 employees and annual total consolidated revenues of around 1,7 billion euros, 89% of which from international sales. In the R&D area, the company invests approximately 10% of reference turnover in the imaging diagnostics and medical devices sectors. The Group’s main products are contrast agents, medical substances used to improve the diagnostic accuracy of biomedical imaging and the care of patients affected by diseases of varying type and severity. Bracco offers an extensive and innovative portfolio of products and solutions for all diagnostic modalities completed by several medical devices and advanced administration systems for contrast imaging products in the fields of cardiology and radiology, developed by it’s American company ACIST. Since its foundation, Bracco has been a socially responsible company in each area of activity - in business as in every other context. Its subsidiary Bracco Imaging is one of the world’s leading companies in the diagnostic imaging field :X-Ray Imaging (including Computed Tomography-CT), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound, and Nuclear Medicine. The Company operates in over 110 markets: in North America through Bracco Diagnostics Inc. USA , and with an affiliate in Montreal (Canada); in Europe, with offices in all major countries; in Japan (BRACCO-EISAI). The Company also operates in South America, South Korea and China through its 70% controlled Joint Venture, Bracco Sine Pharmaceutical Corp. Ltd.